Health Care/Hospital

Long-lasting Chlorine Dioxide (ClO2) Aqueous Solution Presented by Taiko Pharmaceutical and Kitasato University Inactivates over 99.99% of SARS-CoV-2 (COVID-19 Virus)

OSAKA, Japan, June 11, 2021 /PRNewswire/ -- Taiko Pharmaceutical Co., Ltd. based inOsaka, Japan, hereby announced that long-lasting chlorine dioxide (ClO2) aqueous solution (*1) inactivated over 99.99% of SARS-CoV-2 (COVID-19 Virus), including its Alpha and Gamma variants (*2), in a test conducte...

2021-06-11 14:00 2975

Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ selective inhibitor, in relapsed or refractory follicular lymphoma at the European Hematology Association 2021 Congress

SHANGHAI, June 11, 2021 /PRNewswire/ -- Shanghai Yingli Pharmaceuticals Ltd (Yingli Pharma), a clinical stage pharmaceutical company providing new therapies for cancer and metabolic diseases, announced today the topline data from a clinical trial sponsored by the company at the annual meeting of ...

2021-06-11 13:05 2863

Parental education brings large benefits for child survival, researchers find

SEATTLE, June 11, 2021 /PRNewswire/ -- A new study conducted by researchers at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine and the Centre for Global Health Inequalities Research (CHAIN) found significant reductions in children's risk o...

2021-06-11 07:58 3400

Happiness Biotech Entered Into Electric Vehicle Distribution Agreement With Geely's Subsidiary

NANPING, China, June 10, 2021 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer and e-commerce services provider, announced today that Taochejun (Fujian) Automobile Distribution Co., Ltd. ("Taoc...

2021-06-10 21:00 12570

OliPass Expands Scientific Advisory Board by Inviting Experts in Pain To Bolster Phase 2 Clinical Trial Design and Management

SEOUL, South Korea, June 10, 2021 /PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced that it is expanding its Scientific Advisory Board ("SAB") for SCN9A antisense pain killer OLP-1002 to include ProfessorPatrick M. Do...

2021-06-10 21:00 1679

Adopting Cloud Platforms will Improve Federal Healthcare Agency Interoperability and Customer Experience

Government to channel investments toward procuring qualified platforms that embrace multiple customers and stakeholders, finds Frost & Sullivan SANTA CLARA, Calif., June 10, 2021 /PRNewswire/ -- Across most government agencies, there is a rising emphasis on modernizing shared services and the cl...

2021-06-10 18:02 1449

VinBrain and FIT Jointly Release a White Paper on Utilizing Artificial Intelligence in Tuberculosis Screening

HANOI, Vietnam, June 10, 2021 /PRNewswire/ -- On June 10, 2021, VinBrain (Vingroup) and FIT (a German NGO working in the field of Tuberculosis prevention and control) jointly release a white paper on utilizing artificial intelligence (AI) in Tuberculosis (TB) diagnosis and screening inVietnam. Th...

2021-06-10 17:11 2046

Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China

LONDON and RALEIGH, N.C., and SHANGHAI, June 10, 2021 /PRNewswire/ -- Verona Pharma plc (Nasdaq: VRNA) ("Verona Pharma") and Nuance Pharma Limited ("Nuance Pharma"), today announce that the companies have entered into an agreement granting Nuance Pharma, aShanghai-based specialty pharmaceutical c...

2021-06-10 14:00 2707

Enamine implements CDD Vault to digitalize its integrated medicinal chemistry, ADME-PK and screening services

The company's expansion in the biological assay space aided by the data platform SAN FRANCISCO and KYIV, Ukraine, June 10, 2021 /PRNewswire/ -- Enamine, a leading provider of R&D Services as well asScreening Compounds, Fragments, Building Blocks and specialized libraries for Drug Discovery, annou...

2021-06-10 13:57 2138

Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product

SUZHOU, China, June 9, 2021 /PRNewswire/ -- Peijia Medical (HKEX:9996, or " Peijia"), a leading player in China for medical technology, announced a partnership withinQB8, a Boston based medical technology incubator, to explore innovative solutions for Structural Heart Disease. This partnership inc...

2021-06-10 10:26 19754

WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates

WUXI, China and DAEJEON, South Korea, June 10, 2021 /PRNewswire/ -- WuXi XDC ("XDC"), a global CDMO company dedicated to end-to-end bioconjugates services, and LegoChem Biosciences (141080KS,"LCB"), today announced that a Memorandum of Understanding (MOU) was signed to form a strategic partnershi...

2021-06-10 08:30 5633

Canadian Medical Auctions Launches First Auction in Toronto, Canada

TORONTO, June 10, 2021 /PRNewswire/ -- Canadian Medical Auctions, dedicated to the re-marketing and auction of surplus healthcare equipment, is delighted to announce their official launch, as the first specialized medical equipment auction house inCanada. Part of the BMA Group, Canadian Medical ...

2021-06-10 04:47 1687

Zeus Industrial Products to Integrate Catheter-Based Contract Manufacturer CathX Medical

ORANGEBURG, S.C., June 9, 2021 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), the global leader in advanced polymer solutions, announced today that it has finalized an agreement to integrate CathX Medical Inc. (CathX) into its organization. Based inSan Jose, California, CathX is a medical...

2021-06-09 23:00 2219

CHEMriya - Billions of Molecules for R&D: OTAVA and BioSolveIT Team Up

11 Billion Novel Molecules: CHEMriya - OTAVA's On-Demand Chemical Space VAUGHAN, Ontario and SANKT AUGUSTIN, Germany, June 9, 2021 /PRNewswire/ -- Today, Canadian-based compound specialist OTAVA (aka OTAVAchemicals) and German frontrunner cheminformatics firm BioSolveIT announce the release of a ...

2021-06-09 21:00 1830

Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer

SINGAPORE, June 9, 2021 /PRNewswire/ -- Travecta Therapeutics, Pte Ltd., a preclinical stage biopharmaceutical company pioneering a portfolio of product candidates engineered to cross the blood-brain-barrier, today announced the appointment ofCharles S. Ryan, JD, PhD as President and Chief Execut...

2021-06-09 21:00 1892

/C O R R E C T I O N -- Amorepacific/

In the news release, A green tea probiotic strain found by Amorepacific is added to the U.S. FDA's NDI list, issued08-Jun-2021 by Amorepacific over PR Newswire, we are advised by the company that the [in the second, third, fourth and fifth] paragraphs, there are few changes]" as originally issued...

2021-06-09 20:12 2684

China Pharma to Launch Highly Purified NMN+PQQ Product

HAIKOU, China, June 9, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced plans to launch a highly purified NMN+PQQ product following the recent successful completion of a pilot scale ...

2021-06-09 20:00 10171

European Patent Office upholds Curadev's cyclodextrin patent for new composition of matter

SANDWICH, England, June 9, 2021 /PRNewswire/ -- Sulphobutyl ether β-cyclodextrin (SBE-β-CD) is used as an excipient to improve the solubility and stability of a range of active pharmaceutical ingredients, prominent among which is the antifungal drug, voriconazole. Working with ProfessorSteve Wick...

2021-06-09 19:50 2180

Summit Healthcare Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering

HONG KONG, June 9, 2021 /PRNewswire/ -- Summit Healthcare Acquisition Corp. (the "Company") today announced the pricing onJune 8, 2021 of its initial public offering of 20,000,000 units at a price of$10.00 per unit. The units will be listed on the Nasdaq Capital Market and trade under the ticker ...

2021-06-09 19:17 19298

Waterdrop Inc. to Report First Quarter 2021 Financial Results on June 17, 2021

BEIJING, June 9, 2021 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the first quarter end...

2021-06-09 19:15 19162
1 ... 801802803804805806807 ... 856

Week's Top Stories